Top ASX shares to buy now for long-term growth

Let's see what makes these shares top long term picks for Aussie investors.

| More on:
A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Life360 is scaling rapidly in the US and globally, boasting impressive revenue growth and user base expansion, with plenty of room for further monetisation as its market presence strengthens.
  • ResMed capitalises on the massive unmet need in sleep apnoea treatment, leveraging its innovative, connected devices to secure a long-term growth trajectory, making it an attractive buy below peak prices.
  • TechnologyOne thrives with its Software-as-a-Service model, providing dependable revenues and solid growth potential, driven by its ongoing innovation and strong client retention in government and enterprise sectors.

History shows that long-term wealth is built not by predicting short-term volatility, but by owning exceptional businesses and giving them time to compound.

So, if you are searching for high-quality ASX growth shares to hold for many years, read on!

That's because listed below are three standouts that are leaders in their fields and look particularly compelling right now.

Life360 Inc. (ASX: 360)

In recent years, Life360 has quietly become one of the most exciting growth stories on the ASX. The family safety app continues to scale rapidly across the United States and globally, with strong momentum in both users and paying subscribers.

The company's most recent update showed annualised monthly revenue climbing 33% year over year to US$446.7 million, while total paying circles rose 23% to 2.7 million. Importantly, Life360 is now operating profitably, generating positive operating cash flow, and delivering meaningful margin expansion as subscription revenue grows.

What makes Life360 a compelling long-term growth idea is its enormous total addressable market. With over 90 million monthly active users but only a small percentage converting into paying subscribers, even modest improvements in monetisation could drive significant revenue upside. Add to that an expanding suite of premium features and international expansion, and you have an ASX share with a very bright outlook.

ResMed Inc. (ASX: RMD)

ResMed is already a giant in the global medical device market, yet it continues to offer substantial long-term growth potential. The company specialises in devices and software for treating sleep apnoea, which is a chronic condition affecting more than one billion people globally.

And with the vast majority of sufferers remaining undiagnosed, this creates a multi-decade runway for growth. Especially given how ResMed's cloud-connected devices, data analytics platforms, and expanding software ecosystem mean it is positioned as the leader in the field.

Despite its positive long-term outlook, ResMed shares remain well below previous highs, giving investors an opportunity to buy a high-quality ASX stock at a very attractive valuation.

TechnologyOne Ltd (ASX: TNE)

Finally, TechnologyOne is one of the ASX's true software success stories. Its transition to a Software-as-a-Service model has transformed its business, delivering recurring revenue growth, expanding margins, and outstanding cash generation.

The company's government and enterprise clients tend to be sticky, long-term users of its integrated platform. This creates a highly dependable revenue base, allowing TechnologyOne to invest in innovation while continuing to deliver strong returns to shareholders.

With over a decade of uninterrupted profit growth behind it and a massive pipeline of organisations still shifting to cloud-based enterprise systems, TechnologyOne looks well positioned to keep compounding for years to come. In fact, management believes it can double in size every five years.

Motley Fool contributor James Mickleboro has positions in Life360, ResMed, and Technology One. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, ResMed, and Technology One. The Motley Fool Australia has positions in and has recommended Life360 and ResMed. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Five arrows hit the bullseye of five round targets lined up in a row, with a blue sky in the background.
Growth Shares

2 compelling ASX shares this fund manager rates as buys!

These stocks could be underrated buys. Here’s why…

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Growth Shares

2 ASX shares that I rate as buys for both growth and dividends

I’m bullish about the long-term for these businesses.

Read more »

A youthful man looks up thoughtfully at a light bulb above his head.
Share Market News

2 quality ASX shares near 52-week lows worth watching

Two proven businesses. Heavy sell-offs. Is the market offering opportunity?

Read more »

A humanoid robot is pictured looking at a share price chart
Share Market News

What is happening to these ASX software shares?

The recent sell off seems driven by renewed concerns around valuations and AI-driven disruption.

Read more »

Two kids are selling big ideas from a lemonade stand on the side of the road for cheap!
Growth Shares

Experts rate this ASX share as a buy!

A leading fund manager is calling this growing business a buy.

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Growth Shares

2 ASX 200 shares that could be top buys for growth

I’m expecting these two ASX 200 shares to deliver good growth to 2030.

Read more »

A man leaps from a stack of gold coins to the next, each one higher than the last.
Growth Shares

3 quality ASX shares to buy with $10,000

Brokers see upside for these well-run businesses.

Read more »

Growth Shares

These beaten down ASX growth shares could rise 50% to 75%

These growth shares are down but not out according to analysts.

Read more »